Thermo Fisher-Clario deal open for views in EU
MLex Summary: Parties interested in the plan by Thermo Fisher Scientific to take over Clario, a maker of software for drug trials, have 10 days to provide comments to the European...To view the full article, register now.
Already a subscriber? Click here to view full article